CIMAvax-EGF

EGF-depleting vaccine CIMAvax-EGF · Center for Molecular Immunology (CIM)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CIMAvax-EGF, covering 2026-03-11 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer [Phase 2]

See pricing